Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,099 | 0,137 | 21.07. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Fr | hVIVO PLC - Directorate Change | - | RNS | ||
HVIVO Aktie jetzt für 0€ handeln | |||||
09.07. | hVIVO PLC - Notice of Trading Update | - | RNS | ||
30.06. | hVivo reports positive results from its largest lab contract to date | 1 | Sharecast | ||
30.06. | hVIVO reports positive results from Cidara's Phase 2b influenza study | 2 | Investing.com | ||
30.06. | hVIVO PLC - Positive results from client Phase 2b field study | - | RNS | ||
05.06. | hVIVO PLC - Result of AGM | - | RNS | ||
02.06. | DIRECTOR DEALINGS: hVIVO CEO buys shares; Investec execs sell stock | 2 | Alliance News | ||
02.06. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
30.05. | hVIVO stock plunges after contract cancellations in 'depressed' market | 1 | Alliance News | ||
30.05. | Hvivo shares tank after contract cancellations | 4 | Shares | ||
30.05. | AIM WINNERS & LOSERS: hVIVO shares dive on contract cancellations | 1 | Alliance News | ||
30.05. | Hvivo client cancels 'significant' HCT trial contract | 1 | Sharecast | ||
30.05. | hVIVO PLC - Trading update | - | RNS | ||
29.05. | hVIVO PLC - Appointment of Independent Non-Executive Director | - | RNS | ||
12.05. | hVIVO announces annual report and upcoming AGM | 1 | Investing.com | ||
12.05. | hVIVO kündigt Jahresbericht und kommende Hauptversammlung an | 1 | Investing.com Deutsch | ||
12.05. | hVIVO PLC - Annual Report, Notice of AGM & Directorate Change | - | RNS | ||
10.04. | EARNINGS AND TRADING: Castelnau swings to profit; hVIVO sees growth | 2 | Alliance News | ||
10.04. | hVivo reports record full-year revenue, earnings | 1 | Sharecast | ||
10.04. | hVivo's chairman Cathal Friel not seeking re-election | 2 | RTE.ie |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
PLUS THERAPEUTICS | 0,384 | 0,00 % | PLUS THERAPEUTICS, INC. - 8-K, Current Report | ||
LIFEWARD | 0,738 | 0,00 % | Lifeward Ltd.: Administrative Law Judge Determines ReWalk Personal Exoskeleton is "Reasonable and Necessary" for Medicare Beneficiary | MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, June 24, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
JD HEALTH | 5,350 | +0,94 % | JD Health-Aktie mit Kursgewinnen (5,05 €) | An der Börse liegt der Anteilsschein von JD Health aktuell im Plus. Das Wertpapier kostete zuletzt 5,05 Euro. Für die JD Health-Aktie steht gegenwärtig ein Preisanstieg 1,41 Prozent zu Buche. Das Papier... ► Artikel lesen | |
EKSO BIONICS | 3,960 | 0,00 % | Ekso Bionics Holdings, Inc.: Virtual eksoUniversity to Support Continuing Education of PTs and PTAs Across the Country | ||
IMUNON | 0,505 | +5,65 % | Imunon, Inc.: IMUNON Granted Continued Listing Extension by Nasdaq to Complete Compliance Plan | Management provides Nasdaq Hearing Panel with a comprehensive executable plan for long term compliance LAWRENCEVILLE, N.J., July 15, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage... ► Artikel lesen | |
ROCKWELL MEDICAL | 0,950 | -1,76 % | Rockwell Medical signs multi-year supply agreement with Innovative Renal Care | ||
AVINGER | 0,465 | -22,17 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
VIRIDIAN THERAPEUTICS | 14,400 | +0,24 % | Viridian Therapeutics, Inc.\DE - 8-K, Current Report | ||
SINTX TECHNOLOGIES | 2,790 | 0,00 % | SINTX Technologies, Inc.: SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors | New leadership and recapitalization to accelerate commercialization of proprietary silicon nitride technologies in medical and high-growth markets SALT LAKE CITY, Utah, June 12, 2025 (GLOBE NEWSWIRE)... ► Artikel lesen | |
AETHLON MEDICAL | 1,430 | -100,00 % | Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort | SAN DIEGO, July 15, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a clinical-stage biotechnology company developing the investigational Aethlon... ► Artikel lesen | |
STAGEZERO LIFE SCIENCES | 0,028 | -100,00 % | Stagezero Life Sciences Ltd (2): Stagezero, ElevationMD use Aristotle to detect cancer | ||
NEURONETICS | 3,230 | -2,86 % | Neuronetics Appoints New Chief Financial Officer | Steven Pfanstiel, a seasoned financial executive with extensive medical technology and pharmaceutical experience, replaces Steve Furlong as Chief Financial Officer following previously announced succession... ► Artikel lesen | |
ARCH THERAPEUTICS | - | - | Arch Therapeutics, Inc. - 8-K, Current Report | ||
SAVARIA | 12,400 | +0,81 % | Dividendenbekanntmachungen (09.07.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,7 EUR CHINA RAILWAY GROUP LTD CNE1000007Z2 0,1948 HKD 0,0211 EUR CHINA TAIPING INSURANCE... ► Artikel lesen | |
IMAC HOLDINGS | 0,192 | -4,00 % | NSE - IMAC Holdings, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities |